Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 2 records, 1 pages
Search For: Oral Factor Xa Inhibitors
Global Oral Factor Xa Inhibitors Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
16 Oct 2024
Pharma & Healthcare
Oral Factor Xa inhibitors are a class of anticoagulant medications that prevent blood clot formation by directly blocking Factor Xa, an enzyme crucial to the clotting process. Taken orally, these drugs are used to manage and prevent conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and atrial fibrillation (AF).Key examples include rivaroxaban, apixaban, and edoxaban.
USD3480.00
Add To Cart
Global Oral Factor Xa Inhibitors Supply, Demand and Key Producers, 2024-2030
16 Oct 2024
Pharma & Healthcare
Oral Factor Xa inhibitors are a class of anticoagulant medications that prevent blood clot formation by directly blocking Factor Xa, an enzyme crucial to the clotting process. Taken orally, these drugs are used to manage and prevent conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and atrial fibrillation (AF).Key examples include rivaroxaban, apixaban, and edoxaban.
USD4480.00
Add To Cart
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
Search For: Oral Factor Xa Inhibitors
Total: 2 records, 1 pages
Oral Factor Xa inhibitors are a class of anticoagulant medications that prevent blood clot formation by directly blocking Factor Xa, an enzyme crucial to the clotting process. Taken orally, these drugs are used to manage and prevent conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and atrial fibrillation (AF).Key examples include rivaroxaban, apixaban, and edoxaban.
USD3480.00
Add To Cart
Oral Factor Xa inhibitors are a class of anticoagulant medications that prevent blood clot formation by directly blocking Factor Xa, an enzyme crucial to the clotting process. Taken orally, these drugs are used to manage and prevent conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and atrial fibrillation (AF).Key examples include rivaroxaban, apixaban, and edoxaban.
USD4480.00
Add To Cart
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>